RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
13.61
-0.26 (-1.87%)
At close: Jun 20, 2025, 4:00 PM
13.85
+0.24 (1.76%)
After-hours: Jun 20, 2025, 6:05 PM EDT
RxSight Stock Forecast
Stock Price Forecast
The 10 analysts that cover RxSight stock have a consensus rating of "Buy" and an average price target of $39.3, which forecasts a 188.76% increase in the stock price over the next year. The lowest target is $16 and the highest is $73.
Price Target: $39.3 (+188.76%)
Analyst Consensus: Buy
* Price targets were last updated on May 19, 2025.
Analyst Ratings
The average analyst rating for RxSight stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 1 | 2 | 2 |
| Hold | 2 | 2 | 2 | 4 | 3 | 3 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 9 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $17 → $25 | Hold → Buy | Upgrades | $17 → $25 | +83.69% | May 19, 2025 |
| Piper Sandler | Piper Sandler | Hold Initiates $18 | Hold | Initiates | $18 | +32.26% | Apr 15, 2025 |
| UBS | UBS | Strong Buy → Hold Downgrades $45 → $16 | Strong Buy → Hold | Downgrades | $45 → $16 | +17.56% | Apr 9, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $22 → $17 | Hold | Maintains | $22 → $17 | +24.91% | Apr 7, 2025 |
| JP Morgan | JP Morgan | Buy → Sell Downgrades $40 → $17 | Buy → Sell | Downgrades | $40 → $17 | +24.91% | Apr 4, 2025 |
Financial Forecast
Revenue This Year
170.93M
from 139.93M
Increased by 22.16%
Revenue Next Year
206.68M
from 170.93M
Increased by 20.91%
EPS This Year
-0.68
from -0.71
EPS Next Year
-0.54
from -0.68
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 199.0M | 252.8M | 305.3M | |
| Avg | 170.9M | 206.7M | 247.0M | |
| Low | 158.5M | 181.6M | 205.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 42.2% | 47.9% | 47.7% | |
| Avg | 22.2% | 20.9% | 19.5% | |
| Low | 13.3% | 6.2% | -0.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.63 | -0.26 | 0.12 |
| Avg | -0.68 | -0.54 | -0.35 |
| Low | -0.73 | -0.88 | -0.84 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.